Dräger: New research should serve as a ‘wake up call’ for businesses to avoid ‘perfect storm’ for workplace health and safety
New research finds that while the broad majority (96%) of people feel safe at work, a sizeable 65% believe that...
Vaccine
Kicking Off Today! Process Intensified. Drug Manufacturing Accelerated. The Sartorius PI Forum opens in Boston — shaping biomanufacturing’s future
Sartorius launches a premier industry event focused on process intensification (PI) for protein therapeutics and emerging modalities.Forum features expert-led sessions,...
Label-free Detection Market to Accelerate Growth from USD 2.64 Billion to USD 4.48 Billion by 2032 – Meticulous Research®
Rising Pharmaceutical Innovation, AI Integration, and Point-of-Care Testing Applications Drive 9.8% CAGR Growth Across Healthcare and Biotechnology Sectors Worldwide REDDING,...
Risky urgent care provider behavior increased in 2025, Chatmeter analysis finds
Review of provider responses to online reviews also found up to 46% contained potential HIPAA violations SAN DIEGO, June 24,...
New Study Reveals 82% of Physicians Question Safety and Quality of Medical Products They Prescribe
Majority express concerns about medical research integrity due to political and commercial influences and over half report declining confidence in regulatory...
Serina Therapeutics to Present at FORCE Family Office Investor Webinar on June 26, 2025
How Parkinson’s affects million – and why current treatments are not enoughContinuous dopaminergic stimulation (CDS): a next-gen approach to Parkinson’s...
Dupixent® (dupilumab) Approved in the U.S. as the Only Targeted Medicine to Treat Patients with Bullous Pemphigoid (BP)
Approval based on pivotal results showing improvements in sustained disease remission and reductions in itch and oral corticosteroid use compared...
Press Release: Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid
Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid Approval based on pivotal...
NeuralCure AI Launches the First Diagnostic & Digital Twin OS for Preventative Care Clinics
Powering the $600B+ Patient-Led Healthcare Revolution DENVER, June 19, 2025 /PRNewswire/ -- NeuralCure AI today announced the official launch of its...
The Department of Health – Abu Dhabi and Sanofi Forge Strategic Alliance to Accelerate the Development of New Global Vaccines in Abu Dhabi
On the sidelines of a high-level US visit focused on healthcare innovation ABU DHABI, UAE, June 18, 2025 /PRNewswire/ --...
IMUNON Presents Positive Phase 2 Translational Data of IMNN-001 in Advanced Ovarian Cancer at ESMO Gynaecological Cancers Congress 2025
ASCO 2025 overall survival data bolster IMNN-001’s potential in advanced ovarian cancer, supported by robust translational results at ESMO Results...
King Faisal Specialist Hospital & Research Centre and Germfree Laboratories Announce Landmark Advanced Therapy Manufacturing Campus in Riyadh
Unveiled at BIO 2025 in Boston, the project marks a major step toward Saudi Arabia's goal to become a global...
Kontakt.io Launches Temperature Monitoring Solution for Critical Healthcare Supplies
Cloud-based solution monitors temperature and humidity of refrigerators and regulated rooms with real-time alerts to ensure the safety and effectiveness...
C-Path’s New Paper in Nature Reviews Drug Discovery Highlights How to Maximize the Regulatory Impact of Consortium-Based Projects
BRUSSELS and AMSTERDAM, June 16, 2025 /PRNewswire/ -- The Innovative Health Initiative (IHI) and Critical Path Institute® (C-Path) today announced...
Merck Manuals Launches AI-powered Search Tool, Providing Enhanced Access to Trusted Medical Information and Resources
RAHWAY, N.J., June 16, 2025 /PRNewswire/ -- Merck Manuals, a comprehensive digital health resource, announced today it has launched a...
Wingcopter Leverages Ansys Technology to Scale Drone Delivery of Medical Supplies
Wingcopter refines its drone designs with simulation, increasing flight distance while retaining payload capacity and delivering essential supplies faster / Key...
BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer
Acquisition will strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech’s next key milestone in...
BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer
Acquisition will strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech’s next key milestone in...
“STRONGER TOGETHER”: SWITZERLAND CHAMPIONS INTERNATIONAL PARTNERSHIPS AS KEY TO ACCELERATED INNOVATION”, ONCE AGAIN SWITZERLAND IS SHOWCASING ITS BIOTECH EXCELLENCE AT BIO INTERNATIONAL IN BOSTON 16-19 JUNE, 2025
Swiss biotech excellence returns to BIO 2025 in Boston, where Switzerland Global Enterprise presents 45 cutting-edge Swiss companies at the...
Benchling Announces Collaboration with Merck on Vaccine Bioanalysis
Unified platform drives bioanalytical capacity, throughput, and efficiency in regulated environment SAN FRANCISCO, June 11, 2025 /PRNewswire/ -- Benchling announced...